SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-18-010991
Filing Date
2018-08-14
Accepted
2018-08-14 16:03:34
Documents
71
Period of Report
2018-06-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0618_yewbiopharm.htm 10-Q 753904
2 CERTIFICATION f10q0618ex31-1_yewbio.htm EX-31.1 7685
3 CERTIFICATION f10q0618ex31-2_yewbio.htm EX-31.2 7651
4 CERTIFICATION f10q0618ex32_yewbio.htm EX-32 3604
  Complete submission text file 0001213900-18-010991.txt   4752108

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE yewb-20180630.xml EX-101.INS 855961
6 XBRL SCHEMA FILE yewb-20180630.xsd EX-101.SCH 66355
7 XBRL CALCULATION FILE yewb-20180630_cal.xml EX-101.CAL 50862
8 XBRL DEFINITION FILE yewb-20180630_def.xml EX-101.DEF 185982
9 XBRL LABEL FILE yewb-20180630_lab.xml EX-101.LAB 516199
10 XBRL PRESENTATION FILE yewb-20180630_pre.xml EX-101.PRE 333930
Mailing Address 9460 TELSTAR AVENUE, SUITE 6 EL MONTE CA 91731
Business Address 9460 TELSTAR AVENUE, SUITE 6 EL MONTE CA 91731 626-401-9588
Yew Bio-Pharm Group, Inc. (Filer) CIK: 0001548240 (see all company filings)

IRS No.: 261579105 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-54701 | Film No.: 181017303
SIC: 0100 Agricultural Production-Crops
Assistant Director 5